Adapthealth Corp Stock Price, News & Analysis

AdaptHealth Corp. (NASDAQ: AHCO) will announce its Q1 2023 financial results on May 9, 2023, before market opening. The company's management will host a teleconference at 8:30 a.m. ET to discuss these results and business activities with investors and analysts. Interested parties can join the call by calling (800) 245-3047 domestically or (203) 518-9765 internationally, referencing Conference ID: AHCO1Q23. Additionally, a replay of the call will be available for six months on the company's website under the 'Investor Relations' section. AdaptHealth specializes in healthcare-at-home solutions, providing medical equipment and supplies to help patients manage chronic conditions, serving around 3.9 million patients annually across 725 locations in 47 states.

AdaptHealth Corp. (NASDAQ: AHCO) reported its financial results for Q4 and fiscal year 2022, highlighting a net revenue increase of 21% year-over-year, reaching $3.160 billion to $3.240 billion for 2023. Despite a strong revenue growth of 11.1% in Q4, net income fell to $69.3 million, down from $156.2 million in 2021. Adjusted EBITDA in 2022 was $593.8 million, while Q4 EBITDA dropped to $146.0 million. The company aims to implement cost containment programs to align with updated guidance. CEO Steve Griggs emphasized strategic advancements, including a merger integration with AeroCare and commitment to healthcare solutions for chronic patients.